JP2005510462A5 - - Google Patents

Download PDF

Info

Publication number
JP2005510462A5
JP2005510462A5 JP2003520774A JP2003520774A JP2005510462A5 JP 2005510462 A5 JP2005510462 A5 JP 2005510462A5 JP 2003520774 A JP2003520774 A JP 2003520774A JP 2003520774 A JP2003520774 A JP 2003520774A JP 2005510462 A5 JP2005510462 A5 JP 2005510462A5
Authority
JP
Japan
Prior art keywords
microcarrier
oligonucleotide
imp
complex
antigen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003520774A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005510462A (ja
Filing date
Publication date
Priority claimed from US09/927,422 external-priority patent/US7250403B2/en
Priority claimed from US09/927,884 external-priority patent/US7183111B2/en
Application filed filed Critical
Priority claimed from PCT/US2001/025364 external-priority patent/WO2003015816A1/en
Publication of JP2005510462A publication Critical patent/JP2005510462A/ja
Publication of JP2005510462A5 publication Critical patent/JP2005510462A5/ja
Pending legal-status Critical Current

Links

JP2003520774A 2001-08-10 2001-08-13 免疫調節オリゴヌクレオチドの生成及びその使用方法 Pending JP2005510462A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/927,422 US7250403B2 (en) 2000-03-10 2001-08-10 Biodegradable immunomodulatory formulations and methods for use thereof
US09/927,884 US7183111B2 (en) 2000-03-10 2001-08-10 Immunomodulatory formulations and methods for use thereof
PCT/US2001/025364 WO2003015816A1 (en) 2001-08-10 2001-08-13 Immunomodulatory oligonucleotide formulations and methods for use thereof

Publications (2)

Publication Number Publication Date
JP2005510462A JP2005510462A (ja) 2005-04-21
JP2005510462A5 true JP2005510462A5 (enExample) 2008-10-02

Family

ID=27129944

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003520774A Pending JP2005510462A (ja) 2001-08-10 2001-08-13 免疫調節オリゴヌクレオチドの生成及びその使用方法

Country Status (5)

Country Link
EP (1) EP1414490A1 (enExample)
JP (1) JP2005510462A (enExample)
AU (1) AU2001281267B2 (enExample)
CA (1) CA2456201A1 (enExample)
WO (1) WO2003015816A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6207646B1 (en) 1994-07-15 2001-03-27 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules
US20030129251A1 (en) 2000-03-10 2003-07-10 Gary Van Nest Biodegradable immunomodulatory formulations and methods for use thereof
US7129222B2 (en) 2000-03-10 2006-10-31 Dynavax Technologies Corporation Immunomodulatory formulations and methods for use thereof
AU2002231336B2 (en) 2000-12-27 2007-06-28 Surefire Medical, Inc. D/B/A Trisalus Life Sciences Immunomodulatory polynucleotides and methods of using the same
US8158768B2 (en) 2002-12-23 2012-04-17 Dynavax Technologies Corporation Immunostimulatory sequence oligonucleotides and methods of using the same
TW200533750A (en) * 2004-02-19 2005-10-16 Coley Pharm Group Inc Immunostimulatory viral RNA oligonucleotides
WO2010142660A2 (en) * 2009-06-09 2010-12-16 Novartis Ag Drug delivery system
WO2015013673A1 (en) 2013-07-25 2015-01-29 Aurasense Therapeutics, Llc Spherical nucleic acid-based constructs as immunostimulatory agents for prophylactic and therapeutic use

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69838294T2 (de) * 1997-05-20 2009-08-13 Ottawa Health Research Institute, Ottawa Verfahren zur Herstellung von Nukleinsäurekonstrukten
US6562798B1 (en) * 1998-06-05 2003-05-13 Dynavax Technologies Corp. Immunostimulatory oligonucleotides with modified bases and methods of use thereof
AU6425999A (en) * 1998-10-09 2000-05-01 Dynavax Technologies Corporation Anti hiv compositions comprising immunostimulatory polynucleotides and hiv antigens
GB9915204D0 (en) * 1999-06-29 1999-09-01 Smithkline Beecham Biolog Vaccine
MXPA02002107A (es) * 1999-08-27 2003-08-20 Inex Pharmaceuticals Corp Composiciones para estimular la secrecion de citoquina e inducir una respuesta inmune.
US20030129251A1 (en) * 2000-03-10 2003-07-10 Gary Van Nest Biodegradable immunomodulatory formulations and methods for use thereof
US20020107212A1 (en) * 2000-03-10 2002-08-08 Nest Gary Van Methods of reducing papillomavirus infection using immunomodulatory polynucleotide sequences

Similar Documents

Publication Publication Date Title
JP2002513556A5 (enExample)
JP2002531053A5 (enExample)
Hudson et al. Nucleic acid dendrimers: novel biopolymer structures
CA2283464A1 (en) Functional dna clone for hepatitis c virus (hcv) and uses thereof
BE2014C050I2 (en) Circovirus sequences associated with piglet weight loss disease (PWD)
JP2005510462A5 (enExample)
CA2396113A1 (en) Nanoparticles having oligonucleotides attached thereto and uses therefor
JP2004509970A5 (enExample)
ATE465168T1 (de) Xylo-lna analoge
CA2219807A1 (en) Systematic evolution of ligands by exponential enrichment: tissue selex
EP2415481A3 (en) Immunostimulatory viral RNA oligonucleotides
WO1998055495A3 (en) Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof
CA2108466A1 (en) Hcv genomic sequences for diagnostics and therapeutics
CA2198261A1 (en) Hybridization and footprinting methods to characterize the interactions of 16s rrna analogues for identification of novel antibiotics
JP2006527761A5 (enExample)
Garver et al. Boundary of pRNA functional domains and minimum pRNA sequence requirement for specific connector binding and DNA packaging of phage phi29.
US10155946B2 (en) Particle-nucleic acid conjugates and therapeutic uses related thereto
JP2004510160A5 (enExample)
JP2002534531A5 (enExample)
IL153388A0 (en) Manipulation of negative stranded rna viruses by rearrangement of their genes and uses thereof
WO2002101088A3 (en) In vitro capture of nucleic acids via modified oligonucleotides and magnetic beads
JP2003522185A5 (enExample)
EP0689460A4 (en) CYCLOBUTYL ANTISIN OLIGONUCLEOTIDES, PRODUCTION METHODS AND USE THEREOF
CA2226457A1 (en) Oligonucleotides specific for human papilloma virus
WO1996040764A3 (en) Nucleotide and amino acid sequences of hypervariable region 1 of the envelope 2 gene of hepatitis c virus